7. Tornier (TRNX)
Company Profile: Based in Amsterdam, Tornier makes devices for joint replacement and soft-tissue repair.Return Since IPO: 44.3% IPO Date: Feb. 2 Offer Price: Tornier offered 8.8 million shares at $19 per share Analyst Consensus: Tornier is also popular on Wall Street, earning seven "buy" ratings from all seven firms covering the company, including Wells Fargo Securities and JPMorgan.
6. Pacira Pharmaceuticals (PCRX - Get Report) Company Profile: Pacira is a specialty pharmaceutical company. The company's lead drug candidate is Exparel, a long-acting anesthetic/analgesic product for postsurgical pain management. Return Since IPO: 70.9% IPO Date: Feb. 2 Offer Price: Pacira offered 6 million shares at $7 per share Analyst Consensus: Pacira earns high marks with five "buy" ratings from all five research shops covering the stock. They include Piper Jaffray, Wedbush and Brean Murray.